CHAOJU EYE CARE (02219) subscribed to a structured deposit product worth 16 million US dollars.
In the morning of July 23, 2026, Sunrise Ophthalmology (02219) announced that Sunrise Ophthalmology Medical (Hong Kong) Limited (Sunrise Hong Kong, an indirect wholly-owned subsidiary of the company) has further subscribed to a structured deposit product with a principal amount of $16 million provided by JPMorgan Chase Bank.
CHAOJU EYE CARE (02219) announced that on July 23, 2026, CHAOJU EYE CARE Medical (Hong Kong) Limited (hereinafter referred to as "CHAOJU Hong Kong", a wholly-owned indirect subsidiary of the Company) has further subscribed to a structured deposit product provided by JPMorgan Chase Bank with a principal amount of USD 16 million.
The subscription is funded by the Group's surplus cash rather than proceeds from a global offering.
Related Articles
On July 23rd, SAINT BELLA GP (02508) spent 99,000 Hong Kong dollars to repurchase 28,500 shares.
WT GROUP (08422) issued 240 million shares for the rights issue.
HYGEIA HEALTH (06078) spent 1.99805 million Hong Kong dollars to repurchase 196,600 shares on July 23rd.
On July 23rd, SAINT BELLA GP (02508) spent 99,000 Hong Kong dollars to repurchase 28,500 shares.
WT GROUP (08422) issued 240 million shares for the rights issue.
HYGEIA HEALTH (06078) spent 1.99805 million Hong Kong dollars to repurchase 196,600 shares on July 23rd.
RECOMMEND
